Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Airspace SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your facility received FDA warning letter FEI-3002345678 on March 15th citing 3 temperature excursions" (government database with record number)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use government data with dates, record numbers, facility addresses.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
Company: Airspace
Core Problem: Time-critical shipments fail to meet delivery deadlines due to inefficient routing, dispatch delays, and lack of real-time visibility—causing customers to miss critical windows for healthcare procedures, product launches, and supply chain deadlines.
Industries: Healthcare & Life Sciences, Aerospace & Aviation, Semiconductor & High-Tech Manufacturing, Automotive Manufacturing, Medical Devices & Pharma
Company Types: Organ Procurement Organizations (OPOs), Blood and tissue banks, Hospitals and diagnostic labs, Airlines and charter operators, MRO/OEM aerospace providers, Semiconductor manufacturers, Automotive manufacturers, Air ambulance services
Company Size: Mid-market to enterprise; organizations with complex multi-modal logistics needs and time-critical operations
Title: VP of Operations / Supply Chain Director / Logistics Manager
Key Responsibilities: Managing time-critical shipment logistics, Ensuring on-time delivery for perishable/temperature-sensitive materials, Reducing aircraft downtime and production stoppages, Maintaining real-time visibility of critical shipments
KPIs: On-time delivery rate for time-critical shipments, Aircraft/equipment downtime minutes, Cost per critical shipment, Visibility/tracking accuracy, Regulatory compliance for specimen transport
These messages are ordered by quality score, not data source type. The best plays come first regardless of whether they use public data, internal data, or both.
Use public CLIA laboratory registry data to identify high-complexity labs serving rural collection sites, then calculate ground transport times to identify sites where specimen stability windows are exceeded before samples even reach the lab.
Naming all 9 specific Montana towns proves this is real research, not a template. The cost comparison (air vs rejections) is exactly what the lab director needs for budget justification. This is actionable today.
This play requires identifying rural collection sites serving the Billings lab, calculating ground transport times, and comparing air transport costs to rejected specimen costs.
Combined with public CLIA registry data to identify high-complexity labs. This synthesis is unique to your business.Cross-reference CLIA laboratory registry with calculated ground transport times from rural collection sites to identify labs where specimen integrity is compromised due to transit time exceeding stability windows.
23 sites is specific and probably accurate for the coverage area. The 9 sites exceeding stability windows is exactly what the lab director needs to know. This would help fix a real operational problem and gives actionable data with transport solutions.
This play requires analyzing collection site locations, calculating ground transport times, and identifying specimen stability violations based on test type requirements.
Combined with public CLIA registry to identify high-complexity labs. This synthesis is unique to your business.Analyze FDA warning letters to identify temperature excursions, then map them to specific shipping routes to identify root causes beyond just process failures.
They actually dug into which specific route caused the deviations. Memphis-to-Boston in January makes sense meteorologically. Shows understanding that the root cause wasn't just their process. This would help fix the actual problem, not just document it.
Cross-reference FAA aircraft registry with Boeing service bulletins to calculate exact parts requirements for each MRO facility's specific fleet, identifying long-lead parts that create critical path bottlenecks.
847 components for 18 aircraft is specific and verifiable from the service bulletin. The 23 long-lead parts creating bottlenecks is exactly what they need to know. Critical path analysis would help get planes back in service faster. This is actionable today.
Map trauma centers within service radius of blood banks using FDA Blood Establishment Registry, then identify facilities without direct courier contracts that likely rely on ad-hoc STAT services.
6 trauma centers in 15 miles is specific and verifiable. This would help the blood bank understand their service area better. The 4 without contracts is an opportunity they hadn't thought about. Gives names and contacts they can act on today.
This play requires analyzing trauma center locations, transfusion volumes from public data, and cross-referencing with known courier contracts.
Combined with FDA Blood Establishment Registry data. This synthesis is unique to your business.Use FAA aircraft registry to identify specific fleet sizes, then calculate exact parts requirements from emergency airworthiness directives to show MRO facilities the precise scope of their inspection burden.
They actually calculated the parts requirement for the specific fleet size. 18 MAX 9 aircraft is verifiable from FAA registration data. 47 components per aircraft shows they read the actual AD. This would save hours of work pulling the requirements themselves.
Map trauma centers served by blood banks, calculate average response times accounting for traffic patterns, and identify facilities where evening hours (peak trauma time) create delivery challenges.
2 specific trauma centers named - verifiable. Evening hours = 70% of activations shows real operational understanding. Response time analysis would help justify courier investments. Gives something actionable.
This play requires analyzing trauma center locations, calculating drive times accounting for traffic patterns, and identifying peak trauma activation hours.
Combined with public FDA Blood Establishment Registry data. This synthesis is unique to your business.Analyze OPO service areas from OPTN/UNOS registry to identify transplant centers with no direct airport access, then estimate placement volume distribution to quantify the impact of long ground legs.
35% of placements is a significant portion that matters. The 8 centers with no airport access is specific and probably accurate. Shows understanding of multi-modal logistics challenges. Gives routing alternatives that can be evaluated.
This play requires analyzing transplant center locations, airport proximity, and estimated placement volume distribution across the OPO service area.
Combined with public OPTN/UNOS registry data. This synthesis is unique to your business.Analyze flight schedules and ground transport times between OPOs and their transplant centers to identify routes with consistent handoff gaps where organs sit waiting for the next leg.
This is something they could actually use - specific route analysis. 47 centers is verifiable, they did research on the coverage area. The 12 high-risk routes would help prioritize optimization efforts. Easy yes/no question, low commitment.
This play requires analyzing flight schedules, ground transport times, and identifying handoff gap patterns across OPO service areas.
Combined with public OPTN/UNOS registry data. This synthesis is unique to your business.Target pharmaceutical manufacturers with FDA warning letters specifically mentioning transport deviations, focusing on those with active compliance deadlines creating urgency.
Warning letter is public record, they did their homework. Temperature excursions during trial shipments is embarrassing but accurate. The deadline reference creates urgency. Easy question about who's handling it.
Target pharmaceutical manufacturers with FDA Form 483 observations documenting temperature excursions during investigational drug shipments, emphasizing the impact on clinical trial integrity.
Form 483 is public, they did their research. Phase 3 trial impact on efficacy analysis is serious. Shows understanding of clinical trial implications beyond just compliance. Appropriate question about SOP validation.
Target blood banks serving major trauma centers in high-traffic urban areas where peak trauma hours coincide with peak traffic, creating delivery time misses against STAT requirements.
TMC is their biggest customer, this is relevant to operations. The 30-minute requirement vs 38-45 minute reality is accurate. Peak trauma hours timing shows understanding of healthcare operations. Question about alternative routing is appropriate.
Target pharmaceutical manufacturers with FDA warning letters citing specific temperature excursions during investigational drug shipments, highlighting the clinical trial impact.
Specific citation of 3 deviations is verifiable from the warning letter. Phase 3 trial impact is real and costly. Shows understanding of downstream consequences. Question is appropriately targeted.
Target high-complexity CLIA labs serving rural collection sites where ground transport times exceed specimen stability windows for genetic testing.
Billings lab is correct, eastern Montana distance is real. The 48-hour stability vs 52-56 hour transit is a legitimate problem. This shows understanding of specimen integrity challenges. Easy routing question.
Target CLIA labs processing high-complexity genetic testing (BRCA) from rural collection sites where ground transport times violate specimen stability requirements.
BRCA testing is a good example of high-complexity testing they do. The 3 specific Montana towns are real rural sites they serve. 48-hour stability vs 52-56 hour transit is accurate. Question about validation is appropriate.
Target OPOs serving transplant centers 200+ miles away in states with limited evening flight schedules, creating routing challenges during peak procurement hours.
12 centers in WI/IL is probably accurate for their service area. The distance and evening flight challenges are real. Shows understanding of when procurements actually happen (evenings). Easy question about charter evaluation.
Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use public data to find companies in specific painful situations. Then mirror that situation back to them with evidence.
Why this works: When you lead with "Your facility received FDA warning letter citing 3 temperature excursions on March 15th" instead of "I see you're hiring for logistics roles," you're not another sales email. You're the person who did the homework.
The messages above aren't templates. They're examples of what happens when you combine real data sources with specific situations. Your team can replicate this using the data recipes in each play.
Every play traces back to verifiable data. Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| OPTN/UNOS Transplant Registry | OPO name, region, procurement-to-transplant time, center location | OPO route analysis, transplant center mapping |
| CLIA Laboratory Demographics Registry | Laboratory name, address, certificate number, test complexity level | High-complexity lab targeting, specimen transport analysis |
| FDA Blood Establishment Registry | Establishment name, address, blood products manufactured, registration status | Blood bank targeting, trauma center service analysis |
| FMCSA SAFER Database | Carrier name, USDOT number, safety rating, violations, hazmat endorsement | Carrier reliability screening, pharmaceutical shipment qualification |
| FAA Aircraft Registry | Aircraft type, operator name, registration number, airworthiness status | MRO facility targeting, fleet grounding event identification |
| FDA Warning Letters & Inspection Reports | Company name, warning letter date, violation type, compliance deadline | Pharmaceutical manufacturer targeting, compliance pressure identification |